Viridian Therapeutics, Inc.\DE (VRDN) Other Operating Expenses (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$672000.0 for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 1766.67% year-over-year to -$672000.0 in Q1 2026; TTM through Mar 2026 was -$2.3 million, a 379.47% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 427.71% from the prior year.
• Other Operating Expenses advanced to -$672000.0 in Q1 2026 per VRDN's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $33.7 million in Q4 2022 and bottomed at -$2.1 million in Q4 2025.
• The 4-year median for Other Operating Expenses is -$195000.0 (2024), against an average of $4.4 million.
• Across the five-year window, Other Operating Expenses surged 332.31% in 2025 and plunged 1766.67% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $33.7 million in 2022, then tumbled by 100.76% to -$256000.0 in 2024, then plunged by 726.56% to -$2.1 million in 2025, then surged by 68.24% to -$672000.0 in 2026.
• Per Business Quant, the three latest VRDN Other Operating Expenses figures stand at -$672000.0 (Q1 2026), -$2.1 million (Q4 2025), and $453000.0 (Q3 2025).